A BILL 
To amend title XIX of the Social Security Act to exclude 
authorized generic drugs from calculation of the average 
manufacturer price for purposes of the Medicaid drug 
rebate program, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Fair and Accurate 
4
Medicaid Pricing Act of 2019’’ or the ‘‘Fair AMP Act’’. 
5
01:20 Jun 21, 2019
H3276
2 
•HR 3276 IH
SEC. 2. EXCLUDING AUTHORIZED GENERIC DRUGS FROM 
1
CALCULATION OF AVERAGE MANUFACTURER 
2
PRICE UNDER THE MEDICAID DRUG REBATE 
3
PROGRAM; 
EXCLUDING 
MANUFACTURERS 
4
FROM DEFINITION OF WHOLESALER. 
5
(a) IN GENERAL.—Subparagraph (C) of section 
6
1927(k)(1) of the Social Security Act (42 U.S.C. 1396r– 
7
8(k)(1)) is amended— 
8
(1) in the subparagraph heading, by striking 
9
‘‘INCLUSION’’ and inserting ‘‘EXCLUSION’’; 
10
(2) by striking ‘‘a new drug application’’ and 
11
inserting ‘‘the manufacturer’s new drug applica-
12
tion’’; and 
13
(3) by striking ‘‘inclusive’’ and inserting ‘‘exclu-
14
sive’’. 
15
(b) EXCLUDING MANUFACTURERS FROM DEFINI-
16
TION OF WHOLESALER.—Section 1927(k)(11) of the So-
17
cial Security Act (42 U.S.C. 1396r–8(k)(11)) is amend-
18
ed— 
19
(1) by striking ‘‘manufacturers,’’; and 
20
(2) by striking ‘‘manufacturer’s and’’. 
21
(c) EFFECTIVE DATE.—The amendments made by 
22
this section shall take effect on the first day of the first 
23
fiscal quarter that begins after the date of enactment of 
24
this Act. 
25
Æ 
01:20 Jun 21, 2019
H3276
